Literature DB >> 29997205

Transduction with Lentiviral Vectors Altered the Expression Profile of Host MicroRNAs.

He Huang1, Chongyang Zhang1, Bei Wang1, Fei Wang1, Bin Pei1, Chaofei Cheng1, Wei Yang1, Zhendong Zhao2,3,4,5.   

Abstract

RNA interference (RNAi) is widely used in gene knockdown analysis and as a tool to screen host genes involved in viral infection. Owing to the limitations of transducing cells with synthetic small interfering RNAs (siRNAs), lentiviral short hairpin RNA (shRNA) vectors are more widely used. However, we found that stable transduction with lentiviral shRNA vectors inhibited hepatitis C virus (HCV) propagation in human hepatoma cells. We found by microRNA (miRNA) microarray analysis that this inhibition was induced by the alteration of host miRNA expression. In addition to one miRNA (miR-196b-5p) previously reported to be involved in HCV infection, other miRNAs (miR-216a-5p, -216b-5p, 217, and -30b-5p) were found to influence HCV infection in this study. Further studies suggested that this effect was independent of the transcription of shRNAs. The lentiviral vector itself and the integration site of the lentiviral vector might determine the change in miRNA expression. Moreover, the upregulation of JUN contributed to the dysregulation of miR-216a-5p, -216b-5p, and -217 in stably transduced cells. Although the changes in miRNA expression were beneficial for inhibiting HCV infection in our study, this off-target effect should be considered when transduction with lentiviral vectors is performed for other purposes, especially in therapy.IMPORTANCE We found that stable transduction with lentiviral shRNA was able to nonspecifically inhibit HCV infection by the dysregulation of host miRNAs. Previous studies showed that the overexpression of shRNAs oversaturated the host miRNA pathways to inhibit HCV infection. In contrast, the miRNA machinery was not affected in our study. Knockout studies suggested that the nonspecific effect was independent of the transcription of shRNAs. The lentiviral vector itself and the integration sites in the host genome determined the changes in miRNAs. Stable transduction with lentiviral vectors was able to increase the expression of JUN, which in turn upregulated miR-216a-5p, miR-216b-5p, and miR-217. miR-216a-5p and miR-216b-5p might inhibit HCV by suppressing the host autophagic machinery. Our study suggested a novel nonspecific effect of lentiviral vectors, and this side effect should be considered when transduction with lentiviral vectors is performed for other purposes, especially in therapy.
Copyright © 2018 American Society for Microbiology.

Entities:  

Keywords:  hepatitis C virus; lentiviral vector; microRNA; off-target effect; shRNA

Mesh:

Substances:

Year:  2018        PMID: 29997205      PMCID: PMC6146707          DOI: 10.1128/JVI.00503-18

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  50 in total

1.  Induction of an interferon response by RNAi vectors in mammalian cells.

Authors:  Alan J Bridge; Stephanie Pebernard; Annick Ducraux; Anne-Laure Nicoulaz; Richard Iggo
Journal:  Nat Genet       Date:  2003-07       Impact factor: 38.330

Review 2.  Retroviral insertional mutagenesis: past, present and future.

Authors:  A G Uren; J Kool; A Berns; M van Lohuizen
Journal:  Oncogene       Date:  2005-11-21       Impact factor: 9.867

3.  Robust production of infectious hepatitis C virus (HCV) from stably HCV cDNA-transfected human hepatoma cells.

Authors:  Zhaohui Cai; Chen Zhang; Kyung-Soo Chang; Jieyun Jiang; Byung-Chul Ahn; Takaji Wakita; T Jake Liang; Guangxiang Luo
Journal:  J Virol       Date:  2005-11       Impact factor: 5.103

4.  Development of a novel dicistronic reporter-selectable hepatitis C virus replicon suitable for high-throughput inhibitor screening.

Authors:  Weidong Hao; Koleen J Herlihy; Noelle Jie Zhang; Shella A Fuhrman; Chau Doan; Amy K Patick; Rohit Duggal
Journal:  Antimicrob Agents Chemother       Date:  2006-10-23       Impact factor: 5.191

5.  The autophagy machinery is required to initiate hepatitis C virus replication.

Authors:  Marlène Dreux; Pablo Gastaminza; Stefan F Wieland; Francis V Chisari
Journal:  Proc Natl Acad Sci U S A       Date:  2009-08-03       Impact factor: 11.205

6.  Synthetic Vpr protein activates activator protein-1, c-Jun N-terminal kinase, and NF-kappaB and stimulates HIV-1 transcription in promonocytic cells and primary macrophages.

Authors:  Audrey Varin; Anne-Zélie Decrion; Emmanuelle Sabbah; Vincent Quivy; Joséphine Sire; Carine Van Lint; Bernard P Roques; Bharat B Aggarwal; Georges Herbein
Journal:  J Biol Chem       Date:  2005-10-21       Impact factor: 5.157

7.  Vps4 and the ESCRT-III complex are required for the release of infectious hepatitis C virus particles.

Authors:  Lynsey Corless; Colin M Crump; Stephen D C Griffin; Mark Harris
Journal:  J Gen Virol       Date:  2009-10-14       Impact factor: 3.891

8.  Long Non-Coding RNA BST2/BISPR is Induced by IFN and Regulates the Expression of the Antiviral Factor Tetherin.

Authors:  Marina Barriocanal; Elena Carnero; Victor Segura; Puri Fortes
Journal:  Front Immunol       Date:  2015-01-09       Impact factor: 7.561

9.  GeneHancer: genome-wide integration of enhancers and target genes in GeneCards.

Authors:  Simon Fishilevich; Ron Nudel; Noa Rappaport; Rotem Hadar; Inbar Plaschkes; Tsippi Iny Stein; Naomi Rosen; Asher Kohn; Michal Twik; Marilyn Safran; Doron Lancet; Dana Cohen
Journal:  Database (Oxford)       Date:  2017-01-01       Impact factor: 3.451

10.  Genome-wide shRNA screening identifies host factors involved in early endocytic events for HIV-1-induced CD4 down-regulation.

Authors:  Alessia Landi; Jolien Vermeire; Veronica Iannucci; Hanne Vanderstraeten; Evelien Naessens; Mostafa Bentahir; Bruno Verhasselt
Journal:  Retrovirology       Date:  2014-12-13       Impact factor: 4.602

View more
  7 in total

1.  Experimental MicroRNA Targeting Validation.

Authors:  Bala Gür Dedeoğlu; Senem Noyan
Journal:  Methods Mol Biol       Date:  2022

2.  MicroRNAs Regulating Autophagy in Neurodegeneration.

Authors:  Qingxuan Lai; Nikolai Kovzel; Ruslan Konovalov; Ilya A Vinnikov
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

3.  Identification of key genes and long non-coding RNA associated ceRNA networks in hepatocellular carcinoma.

Authors:  Jun Liu; Wenli Li; Jian Zhang; Zhanzhong Ma; Xiaoyan Wu; Lirui Tang
Journal:  PeerJ       Date:  2019-11-01       Impact factor: 2.984

4.  Successfully transfected primary peripherally mobilized human CD34+ hematopoietic stem and progenitor cells (HSPCs) demonstrate increased susceptibility to retroviral infection.

Authors:  Jeffrey Sebrow; Stephen P Goff; Daniel O Griffin
Journal:  Virol J       Date:  2020-02-10       Impact factor: 4.099

5.  Self-assembling ferritin-dendrimer nanoparticles for targeted delivery of nucleic acids to myeloid leukemia cells.

Authors:  Federica Palombarini; Silvia Masciarelli; Alessio Incocciati; Francesca Liccardo; Elisa Di Fabio; Antonia Iazzetti; Giancarlo Fabrizi; Francesco Fazi; Alberto Macone; Alessandra Bonamore; Alberto Boffi
Journal:  J Nanobiotechnology       Date:  2021-06-09       Impact factor: 10.435

6.  Exosomes function as nanoparticles to transfer miR-199a-3p to reverse chemoresistance to cisplatin in hepatocellular carcinoma.

Authors:  Kun Zhang; Chu-Xiao Shao; Jin-de Zhu; Xin-Liang Lv; Chao-Yong Tu; Chuan Jiang; Min-Jie Shang
Journal:  Biosci Rep       Date:  2020-07-31       Impact factor: 3.840

Review 7.  The Role of miRNA in Tumor Immune Escape and miRNA-Based Therapeutic Strategies.

Authors:  Zhengjia Zhang; Qingcai Huang; Liuchunyang Yu; Dongjie Zhu; Yang Li; Zeyu Xue; Zhenglai Hua; Xinyi Luo; Zhiqian Song; Cheng Lu; Ting Zhao; Yuanyan Liu
Journal:  Front Immunol       Date:  2022-01-18       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.